Back

Reconstructing atrio-ventricular interaction in patients with atrial fibrillation with or without heart failure and preserved ejection fraction undergoing pulmonary vein isolation

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Cardiovascular mechanics and functional reserve in advanced heart failure phenotypes Haemodynamics of Heart Failure HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Mr Lukas Semmler

Charite Campus Virchow Clinic, Berlin (Germany)

4 More presentations in this session

Presentation thumbnail
Relationship of intra-abdominal pressure measurement with cardiovascular outcomes in advanced heart failure
Doctor S. Efe (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Interventricular septum displacement implications during exercise in different heart failure phenotypes: limited cardiac reserve, right-ventricle to pulmonary circulation uncoupling, and oxygen uptake
Doctor G. Crisci (Hasselt, BE)
Abstract Slides Video
Presentation thumbnail
Impact of systemic inflammation on exercise hemodynamics in unexplained dyspnea and heart failure with preserved ejection fraction
Doctor J. Heemann (Jette, BE)
Abstract Slides Video
Presentation thumbnail
Associations between cardiopulmonary exercise testing and right heart catheterization with exercise in patients with HFrEF
Doctor A. Ntalianis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular mechanics and functional reserve in advanced heart failure phenotypes

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Left atrial function in various stages of heart failure with preserved ejection fraction and its role after transcatheter tricuspid valve repair
thumbnail
Congress Presentation
Characterising the role of atrial fibrillation in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Left atrial strain measurement in patients with heart failure and atrial fibrillation compared to a control group

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources